SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001557142-17-000067
Filing Date
2017-05-15
Accepted
2017-05-15 09:27:05
Documents
80
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kdmn-20170331x10q.htm 10-Q 1717510
2 EX-31.1 kdmn-20170331xex31_1.htm EX-31.1 20048
3 EX-31.2 kdmn-20170331xex31_2.htm EX-31.2 20012
4 EX-32.1 kdmn-20170331xex32_1.htm EX-32.1 10425
5 EX-32.2 kdmn-20170331xex32_2.htm EX-32.2 10281
  Complete submission text file 0001557142-17-000067.txt   6897850

Data Files

Seq Description Document Type Size
6 EX-101.INS kdmn-20170331.xml EX-101.INS 1211563
7 EX-101.SCH kdmn-20170331.xsd EX-101.SCH 53599
8 EX-101.CAL kdmn-20170331_cal.xml EX-101.CAL 60361
9 EX-101.DEF kdmn-20170331_def.xml EX-101.DEF 276245
10 EX-101.LAB kdmn-20170331_lab.xml EX-101.LAB 423569
11 EX-101.PRE kdmn-20170331_pre.xml EX-101.PRE 443853
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 212-308-6000
Kadmon Holdings, Inc. (Filer) CIK: 0001557142 (see all company filings)

IRS No.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37841 | Film No.: 17841606
SIC: 2834 Pharmaceutical Preparations